The expression of membrane-bound CD14 renders mouse B-1 cells susceptible to LPS. 2001

T Sugiyama, and N Koide, and D Chakravortty, and Y Kato, and M M Mu, and T Yoshida, and T Yokochi
Department of Microbiology and Immunology, and Division of Bacterial Toxin, Research Center for Infectious Disease, Aichi Medical University, Nagakute, Aichi, Japan. sugiyama@aichi-med-u.ac.jp

The surface expression of CD14 on mouse B-1 cells and its role on their response to lipopolysaccharide (LPS) were studied by using the murine TH2.52 B-1 cell line and peritoneal B-1 cells. TH2.52 cells with the B-1 phenotype were found to express membrane-bound CD14. Furthermore, CD14 was expressed on physiological peritoneal CD5+ B-1 cells. The stimulation of CD14-expressing TH2.52 cells with a low concentration of LPS resulted in the activation of nuclear factor (NF)-B and a mitogen-activated protein kinase (MAPK). The LPS-induced NF-B and MAPK activation was markedly inhibited by anti-CD14 antibody. These results suggest that B-1 cells may respond to LPS via membrane-bound CD14.

UI MeSH Term Description Entries
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015870 Gene Expression The phenotypic manifestation of a gene or genes by the processes of GENETIC TRANSCRIPTION and GENETIC TRANSLATION. Expression, Gene,Expressions, Gene,Gene Expressions
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D018950 Lipopolysaccharide Receptors Glycolipid-anchored membrane glycoproteins expressed on cells of the myelomonocyte lineage including MONOCYTES; MACROPHAGES; and some GRANULOCYTES. They function as receptors for the complex of lipopolysaccharide (LPS) and LPS-binding protein. Antigens, CD14,CD14 Antigens,Receptors, Lipopolysaccharide,Soluble CD14,Soluble CD14 Antigen,Soluble CD14 Protein,sCD14,CD14 Antigen,CD14 Monocyte Differentiation Antigen,LPS Receptor,Lipoglycan Receptor,Receptor, LPS,Receptor, Lipoglycan,CD14 Antigen, Soluble,CD14 Protein, Soluble,CD14, Soluble

Related Publications

T Sugiyama, and N Koide, and D Chakravortty, and Y Kato, and M M Mu, and T Yoshida, and T Yokochi
August 2020, Life science alliance,
T Sugiyama, and N Koide, and D Chakravortty, and Y Kato, and M M Mu, and T Yoshida, and T Yokochi
January 1991, Molecular immunology,
T Sugiyama, and N Koide, and D Chakravortty, and Y Kato, and M M Mu, and T Yoshida, and T Yokochi
April 2009, The Journal of clinical endocrinology and metabolism,
T Sugiyama, and N Koide, and D Chakravortty, and Y Kato, and M M Mu, and T Yoshida, and T Yokochi
August 1995, Journal of immunology (Baltimore, Md. : 1950),
T Sugiyama, and N Koide, and D Chakravortty, and Y Kato, and M M Mu, and T Yoshida, and T Yokochi
March 2000, Infection and immunity,
T Sugiyama, and N Koide, and D Chakravortty, and Y Kato, and M M Mu, and T Yoshida, and T Yokochi
August 2019, Nature communications,
T Sugiyama, and N Koide, and D Chakravortty, and Y Kato, and M M Mu, and T Yoshida, and T Yokochi
August 2001, The Journal of clinical investigation,
T Sugiyama, and N Koide, and D Chakravortty, and Y Kato, and M M Mu, and T Yoshida, and T Yokochi
December 2009, The American journal of pathology,
T Sugiyama, and N Koide, and D Chakravortty, and Y Kato, and M M Mu, and T Yoshida, and T Yokochi
March 2015, AIDS (London, England),
T Sugiyama, and N Koide, and D Chakravortty, and Y Kato, and M M Mu, and T Yoshida, and T Yokochi
April 1993, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!